Noumi (NOU) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 Dec, 2025Executive summary
Q1 FY26 revenue reached $162.4 million, a 9.0% increase year-over-year, driven by strong Dairy and Nutritionals growth and stable Plant-based Milks performance.
Operating cash flow for the quarter was $12.8 million, including $3.7 million in legal expenses related to legacy matters.
The Victorian Supreme Court approved the Class Action Settlement, resolving key legacy legal issues.
Unrestricted cash at quarter-end was $21.9 million, with $10.0 million in undrawn facilities, totaling $31.9 million in available liquidity.
Financial highlights
Consolidated Q1 FY26 revenue increased by $13.4 million (9.0%) compared to Q1 FY25.
Dairy and Nutritionals revenue rose by $13.9 million (13.7%) year-over-year, while Plant-based Milks revenue declined by $0.5 million (1.0%).
Operating cash flow was $12.8 million, positively impacting the cash balance, which increased by $5.7 million from Q4 FY25.
Capital expenditure for the quarter was $1.1 million.
Outlook and guidance
Management is pleased with Q1 FY26 performance but notes variability in month-to-month market conditions.
Planning has commenced for the maturity of Convertible Notes in 2027.
Latest events from Noumi
- EBITDA up 23.3% to AUD 33.9m, but AUD 610.4m convertible notes maturity risk persists.NOU
H1 202624 Feb 2026 - Record adjusted EBITDA and revenue growth offset by non-cash charges and global dairy headwinds.NOU
H2 202423 Jan 2026 - Net loss widened on non-cash items, but Plant-based Milks drove record EBITDA growth.NOU
H1 202523 Dec 2025 - EBITDA up 13% to AUD 57.4m, net loss AUD 150m, growth focus and 2027 note maturity planning.NOU
H2 202523 Nov 2025 - Record growth in plant-based milks and strategic expansion drive robust FY25 results.NOU
AGM 2025 Presentation5 Nov 2025 - Revenue up 2.6% to $149.1M, strong plant-based growth, solid cash flow, dairy exports weak.NOU
Q1 202513 Jun 2025